Virtu Financial LLC Athenex, Inc. Transaction History

Virtu Financial LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$0.24 - $1.11 $11,590 - $53,606	-48,294 Reduced 76.54%	14,803 $4,000
Q2 2022 Aug 09, 2022	BUY	$0.41 - $0.91 $25,869 - $57,418	63,097 New	63,097 $26,000
Q4 2021 Feb 17, 2022	SELL	$1.36 - $2.94 $42,761 - $92,439	-31,442 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.97 - $4.84 $20,620 - $33,604	6,943 Added 28.34%	31,442 $95,000
Q2 2021 Sep 17, 2021	SELL	$3.71 - $5.13 $112,720 - $155,864	-30,383 Reduced 55.36%	24,499 $113,000
Q1 2021 May 19, 2021	BUY	$4.08 - $14.75 $223,918 - $809,509	54,882 New	54,882 $236,000
Q4 2020 Feb 24, 2021	SELL	$11.06 - $14.01 $117,888 - $149,332	-10,659 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$10.26 - $14.55 $109,361 - $155,088	10,659 New	10,659 $129,000
Q3 2019 Nov 20, 2019	SELL	$12.16 - $21.0 $189,696 - $327,600	-15,600 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$9.44 - $19.8 $147,264 - $308,880	15,600 New	15,600 $309,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.